Received Jun 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
she was recently in the hospital and is feeling short of breath/winded today; This non-serious case was reported by a consumer via call center representative and described the occurrence of shortness of breath in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date in 2018). In FEB-2019, the patient received the 2nd dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix, the patient experienced shortness of breath (Verbatim: she was recently in the hospital and is feeling short of breath/winded today). The outcome of the shortness of breath was not resolved. It was unknown if the reporter considered the shortness of breath to be related to Shingrix. Additional Information: GSK Receipt date: 08-JUN-2026 The patient stated that had received shot 1 of Shingrix in late 2018 and shot 2 of Shingrix in FEB-2019. The patient had gone to the pharmacy recently, where patient had been told that needed to have her shingles shot updated, but patient had declined a third dose. The patient stated that had recently been in the hospital and had felt short of breath/winded on that day. The batch number had not been provided upon follow-up with the reporter.